Integra LifeSciences Expands Spinal Deformity Range With New Stiffer Rod

Integra LifeSciences Holdings Corporation has added a second cobalt chrome rod to its Daytona™ and Malibu™ Spinal Systems. The company says its new ESS+ rod, provides additional strength and stiffness over the existing cobalt chrome iteration.

Integra Daytona

In short

Integra LifeSciences Holdings Corporation has added a second cobalt chrome rod to its Daytona™ and Malibu™ Spinal Systems. The company says the new rod, the Enhanced Strength and Stiffness (or ESS+) rod, is stronger and stiffer than the existing cobalt chrome iteration.

Background

Integra’s ESS+ rod will enter controlled market release in the third quarter of 2013 and will add to the multiple rod options in the company’s various spinal deformity correction systems, including titanium alloy, stainless steel and cobalt chrome.

The Daytona Deformity System, powered by Malibu technology, is designed to address standard to complex deformity cases in adult patients. It combines unique implant designs, materials and innovative instrumentation to create a highly versatile system. The screws feature extended travel housings for 30mm of built in rod reduction, and the intuitive instrumentation accommodates multiple derotation techniques. The new ESS+ rod is available in straight and lordotic/kyphotic configurations.

Physician comments

“Deformity correction is a specialized segment of the spinal fixation market, where cases are often complex and outcomes may be life-changing,” said Brian B. Nielsen, MD, Tucson Orthopaedic Institute. “The type of rod material is frequently dictated by the patient’s condition. The ESS+ rod is a welcome addition to Integra’s product line, and demonstrates their commitment to provide us with a broader selection of treatment options.”

Company comments

“Integra’s development efforts underscore our commitment to provide surgeons with comprehensive solutions for deformity correction procedures,” said Kirt Stephenson, Integra’s President, U.S. Spine. “We will continue to focus on the needs of surgeons and seek their input as we grow our presence in the spine market.”

Source: Integra LifeSciences Corp., Globe Newswire

published: March 26, 2013 in: Launches / Withdrawals, Spine

Most read

Latest

^